Earnings Call · Q2 FY2022·2022-08-07

Q2 22EPS -43.92%·Rev n/aQ1 22EPS -7.23%·Rev n/aQ4 21EPS -23.03%·Rev n/aQ3 21EPS 0.00%·Rev n/a⚠ consensus missing

PTC THERAPEUTICS, INC. PTCT

Kylie O'Keefe — Investor Relations or Corporate Communications

Stuart Peltz — Chief Executive Officer

Matthew Klein — Chief Operating Officer

Eric Pauwels — Chief Business Officer

Emily Hill — Chief Financial Officer

+8.7%1d on move date+8.8% vs SPY3d+5.1%5d+5.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PTCT calls or request research access.

More PTCT calls Browse calls Request research access